212-681-1575
Feb

15

Could Vaccine Under Development “Eliminate&#...

Posted by

Label: Featured News


It has been years since there has been a significant breakthrough in the fight against lung cancer or mesothelioma. The cancers are still a death sentence for many patients, with the 10-year survival rate just five percent. However, scientists continue

Read Full Story

Want Specific topic updates?


The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for medical professionals caring for cancer patients. The Society has a goal to improve the quality of care in the field of oncology.  Now, to assist medical

Read Full Story

Want Specific topic updates?


Researchers continue to look for an effective tool that can be used for the early detection of cancer and to track the effectiveness of treatment. Now, one company reports that by pairing its liquid biopsy analyzer tool with another company’s

Read Full Story

Want Specific topic updates?


Boehringer Ingelheim has announced that the UK is following in the footsteps of the U.S. in the latest designation for the company’s drug nintedanib. In December 2016, the U.S. Food and Drug Administration granted orphan drug designation to the investigational

Read Full Story

Want Specific topic updates?


laboratory

Patients, physicians and researchers in the mesothelioma community suffered a serious setback last month when Aduro Biotech announced they terminated the Phase Ib clinical trial for its drug known as CRS-207. MesotheliomaHelp has reported multiple times on the “encouraging results”

Read Full Story

Want Specific topic updates?

1 2 3 6